22) Yimpreeda H, Laowittawat C, Siritutsoontorn S, Rojvirat P, Kumphune S, Jitrapakdee S*. Erianin inhibits 3T3-L1 adipocyte differentiation through downregulation of CCAAT-enhancer binding protein-α and peroxisome proliferator-activated receptor-γ, lipogenic genes and impairment of mitochondrial respiration. Adipocyte 2026;15(1):2601405.
21) Yatmark P, Anutagerngkun P, Huaijantug S, Tantisira MH, Svasti S, Morales NP*. A standardized extract of Centella asiatica (ECa 233) protects against liver injury and fatty liver in wild-type and beta-thalassemia mice with iron overload. Adv Pharmacol Pharm Sci 2026;2026(1):7087725.
20) Watthaisong P, Kantiwiriyawanitch C, Jitkaroon W, Phintha A, Klayparn I, Lawan N, Kamutira P, Sasaki D, Visitsatthawong S, Maenpuen S, Tinikul R, Sucharitakul J, Nishihara R, Niwa K, Nakajima Y, Ohmiya Y, Chaiyen P*. Red-shifted d-luciferin analogues and their bioluminescence characteristics. RSC Chem Biol 2026;7(1):67-80.
19) Vetkama W, Deethaisong T, Manjit P, Tinikul R, Sobhon P, Tinikul Y*. Examination of the role of neuropeptide F in promoting food intake, digestive functioning, growth performance, and expression of immune-related genes in juvenile giant freshwater prawn, I. Aquaculture 2026;614:743587.
18) Venkatraman S, Pongchaikul P, Balasubramanian B, Anurathapan U, Meller J, Tohtong R, Hongeng S, Chutipongtanate S*. Transcriptomic correlation identifies cell model representatives for MYCN-amplified pediatric neuroblastoma, downstream impact of model choice on functional interpretation, and potential drug repositioning candidates. OMICS 2026;30(3):134-45.
17) Thunwiriya P*, Phetruen T, Chaiwijit P, Tonawannakorn C, Dekham K, Thadtapong N, Chaturongakul S, Charoensawan V*, Chanarat S*, Pakotiprapha D*, Hanutsaha P*. Comparative evaluation of stability, efficacy, and sterility in five repackaged intravitreal anti-vascular endothelial growth factor medications. Sci Rep 2026;16(1):9306.
16) Suriyaprom K*, Pongpoungphet N, Promyos N, Sornwatana T. Antioxidant and anti-inflammatory activities of Peptides derived from Fructus bruceae. J Integr Sci Technol 2026;14(3):1543.
15) Suksomjaisaman K, Thananon K, Mangkalee M, Thotsaporn K, Tinikul R, Schulte A, Wangkanont K*, Sirikantaramas S*, Sucharitakul J, Chaiyen P. Structure and reaction mechanisms of a two-component indole monooxygenase from Acinetobacter baumannii. Arch Biochem Biophys 2026;776:110681.
14) Sripaturad P, Keo S, Wongpan A, Siri W, Tana-Atsawapon N, Luksirikul P, Katewongsa KP*, Baowan D*. Experimental and theoretical evaluation of geometry-dependent doxorubicin loading onto cerium oxide nanoparticles via van der Waals interaction modeling. Sci Rep 2026;16(1):6169.
13) Siritutsoontorn S, Manohong P, Sawektreeratana N, Kuhakarn C, Katewongsa KP*, Jitrapakdee S*. Riboflavin-PLGA nanoparticles enhance the effectiveness of the pyruvate carboxylase inhibitor ZY-444 in targeting lipogenesis in colon and breast cancer. Sci Rep 2026;16(1):125.
12) Ratnarathorn N, Panyain N, Noiphrom J, Thaveekarn W, Taewcharoen N, Khow O, Chanhome L, Laoungbua P, Tawan T, Kumkate S*. Interspecific and intraspecific variation in venom proteomics, composition, and antivenom efficacy of Thai cobras (Naja spp.): highlighting the distinct profile of the newly identified Naja fuxi. Acta Trop 2026;278:108065.
11) Prommi A, Sawaswong V, Petsong S, Wongjarit K, Somsukpiroh U, Payungporn S*, Rotcheewaphan S*. Genomic analysis of Mycobacterium abscessus isolates from non-cystic fibrosis patients in Thailand: phylogeny, subspecies distribution, and antimicrobial resistance profiles. J Microbiol Immunol Infect 2026;59(2):251-8.
10) Oungbamnet C, Hinwan Y, Nithimongkolchai N, Sawaswong V, Chitcharoen S, Faksri K, Sirichoat A*. Whole-genome and pangenome insights into Mycobacterium colombiense clinical isolates from human infections. PeerJ 2026;14:e20716.
9) Nuanpirom J, Charoensawan V*. Multimodal bioinformatic analyses of genome-scale expression beyond gene-centric differential expression. Brief Bioinform 2026;27(2).
8) Ngernsombat C, Suriya U, Udompaisarn S, Panomchoeng N, Janvilisri T*. Candesartan cilexetil as a repurposed therapeutic candidate for nasopharyngeal carcinoma: integrated in vitro and in silico analyses. EXCLI J 2026;25:204-21.
7) Myint KZ, Mongkonsiri T, Jinawath A, Tohtong R*. Association of a CD44s-v5-v6 null phenotype with advanced stage cholangiocarcinoma: a preliminary study. Cancers (Basel) 2026;18(1):21.
6) Manohong P, Sawektreeratana N, Nuchpun S, Kumkoon T, Payomhom P, Laowittawat C, Jitrapakdee S, Lee HM, Reutrakul V, Kuhakarn C, Katewongsa KP*. Encapsulation of plant-derived cycloheptapeptide mallotumide A in riboflavin-modified poly(lactic-co-glycolic acid)/chitosan nanoparticles. Macromol Mater Eng 2026;311(1):e00385.
5) Kidoikhammouan S, Mahalapbutr P, Ma-In P, Lert-Itthiporn W, Deenonpoe R, Suriya U, Wongkham S, Seubwai W*. Integrated transcriptomic and molecular docking analysis identifies Rhotekin 2 as a promising therapeutic target for overcoming gemcitabine resistance in cholangiocarcinoma. Biomed Rep 2026;24(5):52.
4) Khongkool K, Taweechotipatr M, Payungporn S, Sawaswong V, Lertworapreecha M*. Superior probiotic potential of Saccharomyces cerevisiae YH14: in vitro and in vivo evaluation for animal nutrition and health. Probiotics Antimicrob Proteins 2026;18(2):2235-49.
3) Chulalaksananukul P, Jafari S, Shiekh KA, Kijpatanasilp I, Pholmanee N, Harnvoravongchai P, Janvilisri T, Assatarakul K*. Sustainable valorization of porcine placenta through microencapsulation: a circular economy approach to functional ingredient development. Sustain Food Technol 2025;4(1):297-309.
2) Chhay C, Lohitnawin M, Wongphatcharachai M, Jariyahatthakij P, Jensen AN, Srichana P, Jensen LT*. Enhanced lycopene fortification in eggs using poultry feed containing a carotenoid-oil preparation derived from metabolically engineered baker’s yeast. Sci Rep 2026;16(1):7354.
1) Asavapanumas N, Chaiwijit P, Suksatu A, Kasemsinsup S, Saikachain N, Chantaraamporn J, Chieowisaman S, Nguantad S, Jevapatarakul D, Thungsatianpun N, Pornsukjantra T, Chokpanuwat T, Manopwisedjaroen S, Bhukhai K, Wongtrakoongate P, Hongeng S, Matangkasombut P, Charoensawan V, Thitithanyanont A*. Identifying GFAP-expressing cell susceptibility to SARS-CoV-2 infection using human iPSC-derived neural cells. Sci Rep 2026;16(1):10433.
Update: 5-May-2026